5 Total results for product and free and sample content found
Biomedtracker
By Patricia Giglio 08 Oct 2020
Get an inside view into the trends powering COVID-era deal making in the life sciences with your free copy of “Biopharma Partnering and Financing Trends, H1 2020”. Informa Pharma Intelligence takes you inside the forces shaping the industry
Topic BIO-Europe
Scrip
By Lucie Ellis 21 Mar 2017
The microbiome market will see its value rise to $500m by 2022, and higher during the next decade. The key driver will be the increase in biotech and pharma firms looking at the emerging research space for new therapeutic options to treat chronic conditions such as Crohn’s disease.
Topic BIO-Europe
Scrip
By Lucie Ellis 21 Mar 2017
The microbiome market will see its value rise to $500m by 2022, and higher during the next decade. The key driver will be the increase in biotech and pharma firms looking at the emerging research space for new therapeutic options to treat chronic conditions such as Crohn’s disease.
Topic BIO-Europe
Scrip
By Lucie Ellis 21 Mar 2017
The microbiome market will see its value rise to $500m by 2022, and higher during the next decade. The key driver will be the increase in biotech and pharma firms looking at the emerging research space for new therapeutic options to treat chronic conditions such as Crohn’s disease.
Topic BIO-Europe
Scrip
16 Mar 2017
The 11th annual BIO-Europe Spring conference is just around the corner. The Pharma Intelligence team has several exciting activities lined up and we hope to see you there.
Topic BIO-Europe
No Records Found
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.
Contact us for product technical and account support.
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: